Warning: The NCBI web site requires JavaScript to function. more...
HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure.
van Hal SJ, Herring B, Deris Z, Wang B, Saksena NK, Dwyer DE.
Retrovirology. 2009 Feb 9;6:12.
Related citations
Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance.
Tschochner M, Chopra A, Maiden TM, Ahmad IF, James I, Furrer H, Günthard HF, Mallal S, Rauch A, John M.
Antivir Ther. 2009;14(7):953-64.
Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F, Malet I, D'Arrigo R, Antinori A, Marcelin AG, Perno CF.
AIDS Rev. 2009 Jan-Mar;11(1):17-29. Review.
Lack of primary mutations associated with integrase inhibitors among HIV-1 subtypes B, C, and F circulating in Brazil.
Passaes CB, Guimarães ML, Fernandez SL, Lorete Rdos S, Teixeira SL, Fernandez JC, Morgado MG.
J Acquir Immune Defic Syndr. 2009 May 1;51(1):7-12.
Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection.
Garrido C, Geretti AM, Zahonero N, Booth C, Strang A, Soriano V, De Mendoza C.
J Antimicrob Chemother. 2010 Feb;65(2):320-6. Epub 2009 Dec 9.
Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance.
Lataillade M, Chiarella J, Kozal MJ.
Antivir Ther. 2007;12(4):563-70.
Potential drug resistance polymorphisms in the integrase gene of HIV type 1 subtype A.
Herring BL, Cunningham AL, Dwyer DE.
AIDS Res Hum Retroviruses. 2004 Sep;20(9):1010-4.
Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes.
Maïga AI, Malet I, Soulie C, Derache A, Koita V, Amellal B, Tchertanov L, Delelis O, Morand-Joubert L, Mouscadet JF, Murphy R, Cissé M, Katlama C, Calvez V, Marcelin AG.
Antivir Ther. 2009;14(1):123-9.
Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro.
Malet I, Delelis O, Valantin MA, Montes B, Soulie C, Wirden M, Tchertanov L, Peytavin G, Reynes J, Mouscadet JF, Katlama C, Calvez V, Marcelin AG.
Antimicrob Agents Chemother. 2008 Apr;52(4):1351-8. Epub 2008 Jan 28.
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients.
Piralla A, Paolucci S, Gulminetti R, Comolli G, Baldanti F.
Virol J. 2011 Mar 31;8:149.
Analysis of natural sequence variation and covariation in human immunodeficiency virus type 1 integrase.
Myers RE, Pillay D.
J Virol. 2008 Sep;82(18):9228-35. Epub 2008 Jul 2.
Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors.
Ceccherini-Silberstein F, Malet I, Fabeni L, Dimonte S, Svicher V, D'Arrigo R, Artese A, Costa G, Bono S, Alcaro S, Monforte A, Katlama C, Calvez V, Antinori A, Marcelin AG, Perno CF.
J Antimicrob Chemother. 2010 Nov;65(11):2305-18. Epub 2010 Sep 3.
Natural polymorphisms of HIV-1 CRF01_AE integrase coding region in ARV-naïve individuals in Cambodia, Thailand and Vietnam: an ANRS AC12 working group study.
Nouhin J, Donchai T, Hoang KT, Ken S, Kamkorn J, Tran T, Ayouba A, Peeters M, Chaix ML, Lien TX, Nerrienet E, Ngo-Giang-Huong N.
Infect Genet Evol. 2011 Jan;11(1):38-43. Epub 2010 Nov 19.
Natural variation of HIV-1 group M integrase: implications for a new class of antiretroviral inhibitors.
Rhee SY, Liu TF, Kiuchi M, Zioni R, Gifford RJ, Holmes SP, Shafer RW.
Retrovirology. 2008 Aug 7;5:74.
Genetic diversity on the integrase region of the pol gene among HIV type 1-infected patients naive for integrase inhibitors in São Paulo City, Brazil.
Arruda LB, Fonseca LA, Duarte AJ, Casseb J.
AIDS Res Hum Retroviruses. 2010 Jan;26(1):105-7.
Natural polymorphisms of integrase among HIV type 1-infected South African patients.
Fish MQ, Hewer R, Wallis CL, Venter WD, Stevens WS, Papathanasopoulos MA.
AIDS Res Hum Retroviruses. 2010 Apr;26(4):489-93.
Genetic variation of the HIV-1 integrase region in newly diagnosed anti-retroviral drug-naïve patients with HIV/AIDS in Korea.
Kim JY, Kim EJ, Choi JY, Kwon OK, Kim GJ, Choi SY, Kim SS.
Clin Microbiol Infect. 2011 Aug;17(8):1155-9. doi: 10.1111/j.1469-0691.2010.03392.x. Epub 2010 Dec 3.
Resistance to HIV-1 integrase inhibitors: A structural perspective.
Mouscadet JF, Delelis O, Marcelin AG, Tchertanov L.
Drug Resist Updat. 2010 Aug-Oct;13(4-5):139-50. Epub 2010 Jun 8. Review.
Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors.
Low A, Prada N, Topper M, Vaida F, Castor D, Mohri H, Hazuda D, Muesing M, Markowitz M.
Antimicrob Agents Chemother. 2009 Oct;53(10):4275-82. Epub 2009 Aug 3.
Appearance of Drug Resistance-Associated Mutations in Human Immunodeficiency Virus Type 1 CRF01_AE Integrase Derived from Drug-Naive Thai Patients.
Isarangkura-Na-Ayuthaya P, Kaewnoo W, Auwanit W, de Silva UC, Ikuta K, Sawanpanyalert P, Kameoka M.
AIDS Res Hum Retroviruses. 2010 Dec;26(12):1341-3. Epub 2010 Sep 13.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on